Noticias > Portada

Noticias

07/06/2017

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

ProSciento and OWL Metabolomics announced an exclusive, multi-year collaboration aimed at identifying individuals who are eligible for enrollment into clinical trials of therapeutic candidates to treat NAFLD and NASH using OWL?s non-invasive, lipidomics-based diagnostic assays.

04/05/2017

OWL Metabolomics and Sanyal Biotechnology LLC Announce Strategic Partnership with Overseas Expansion

OWL Metabolomics is planning to open its American office in the VABeachBio biotechnology incubator in Virginia Beach, USA, co-locating with Sanyal Biotechnology; likewise, Sanyal Biotechnology is planning to open its European office under the auspices of OWL in its location in Bilbao, Spain.
By this agreement, made at last ILC /EASL Congress in Amsterdam, the two companies will share resources in their respective locations as they combine efforts to better serve their pharmaceutical clients.

Consulte histórico de noticias

ONE WAY LIVER, S.L
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - España
Teléfono: +34 94 431 85 40
Fax: +34 94 431 71 40

A través de su web, OWL pretende contribuir a la divulgación de la ciencia y a la mejora de la salud y el bienestar de las personas. El carácter de la web es
meramente divulgativo y en ningún caso puede sustituir la relación médico-paciente. Ante cualquier duda, acuda a su centro médico o especialista.
Última actualización: 08/06/2017

Con la colaboración de: